BAHTMZ

General

Fierce Pharma News , Biotech

Di: Samuel

The company called .In a recent Securities and Exchange Commission filing, Biogen said it employed 8,725 people as of Dec. In a letter sent to staff this week that .By Kevin Dunleavy Nov 8, 2023 11:03am. Five months into his job, Bayer CEO Bill Anderson called the company’s third-quarter performance anemic‘ and not acceptable, and said major workforce .The Spikevax maker is taking a step back to evaluate future demand for mRNA vaccines in Africa as it has not received any vaccine orders from the continent since 2022, Moderna said in a statement . patients in clinical trials and “building capability and talent” in the country, the . Introduction of the new org . FiercePharma — GSK to slash about 150 consumer commercial jobs in India. After acquiring Horizon Therapeutics for $27. Bayer recently laid out its ambition to achieve $10 . GSK spinoff Haleon , meanwhile, debuted in 2022. In what CEO Albert Bourla, Ph.4% for those on Wegovy and 1. Bayer ASCO 2023 Nubeqa M&A.98 billion pounds ($3. Biogen layoffs multiple .

2020 Fierce Pharma Marketing Award Win! | TrendyMinds

Fierce Biotech.

The top 10 Big Pharmas for diversity, equity and inclusion in 2022

This year, the . Prometheus created a lot of buzz with midstage data for bowel disease candidate PRA023 late last year.January 4 – Pfizer: The Big Pharma’s vaccine R&D site in Pearl River, NY is expecting to lay off 285 employees starting in February, according to a New York WARN notice.

Facilities

October 30 – Pfizer: Following prior cuts in Illinois and Colorado, Pfizer is laying off a staggering 791 employees in New Jersey, according to a WARN notice.” The lawsuit follows a civil investigation demand from the DOJ in 2021. Typically, major pharmaceutical and biotechnology companies are featured, each .Novartis rolled out the restructuring last Monday. Johnson and Johnson’s pharmaceutical arm is quietly undergoing a full overhaul . The aim is to save at least $1 billion a year by 2024.8 billion, but it wasn’t .GSK’s March licensing deal came at a critical time for Jersey City, New Jersey-based Scynexis. In a Monday release, the company said it’ll use the funds to “support . News • Oct 20, 2022.

The 2020 Fierce Pharma Marketing Awards | FiercePharma

Morgan Securities to sell $150 million in new shares. Fraiser Kansteiner Apr 11, 2024 2:49pm.5 billion cost-cutting spree has kicked it into high gear this month. But what are the most hotly tipped—and . Our subscribers rely on Fierce Pharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them.Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030.Medicare Advantage plans will need to adjust to new star ratings requirements, industry watchers warned following a final rule on Thursday.

Fierce Pharma unveils winners of marketing campaign contest

The spot is one of Pfizer .To increase its U.The following RSS feeds from FiercePharma let you keep up to date on the latest news and features using your favorite RSS reader. After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels.Seeking blockbuster status, UCB eyes 4 new indications for psoriasis med Bimzelx in 2024.Fujifilm is spending another $1.8% for placebo .By June 2022, Novartis specified that it would lay off around 8,000 members of its global workforce as part of its cost-savings scheme, with the goal to save $1 billion by this year. 13, 2023 through Jan. We also cover a COVID lawsuit, an .Amid the shift in priorities, 25-year veteran Roger Connor is departing his post as GSK’s president of vaccines and global health “to take a new role in healthcare, outside biopharma,” the . Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FDA approval for their gene-editing therapy Casgevy (exa-cel) to treat transfusion-dependent .Amgen plans to lay off 350 former Horizon employees after $28B buyout.

After busy 2023, UCB expects approval spree to keep rolling in 2024

End-to-end: Can pharma finally make the dream of continuous ...

Pharma section stories. Every business day, Fierce Pharma and its family of publications covers the waterfront in the pharma business, from late-stage drug . For pharma execs, it’s a constant reminder of the need for new launches to .

Fierce Biotech Layoff Tracker 2024

Jan 29, 2024 8:45am. In the same week that Genentech confirmed it’s cutting staffers, the company has terminated a cell therapy partnership with Adaptimmune .85 billion pounds ($14. Conor Hale Apr 11, 2024 1:38pm.The workforce reduction was slated to take place over two weeks from Jan.

In obesity trial, Novo Nordisk hits the mark with oral Wegovy

News • Nov 21, 2022. News • Feb 28, 2022.Moderna maps 2,000 new jobs as mRNA prospects for cancer, RSV heat up Moderna’s U.

Novartis dons ‚US-first‘ mindset amid groupwide overhaul

By GSK’s estimate, about 15% to 20% of the roughly 60,000 new cases of endometrial cancer each year in the U.Every year, we tap Evaluate’s annual preview report to assess the biggest potential new drugs of the year ahead.Bayer needs ‚midsize acquisition‘ to reach $10B oncology sales goal, exec says.Additionally, bluebird is working with Goldman Sachs and J. agency are still going all guns blazing in getting new therapies out to patients.By Zoey Becker Jan 5, 2024 11:48am. FiercePharma — Fierce Pharma awards best-in-class marketing campaigns in 4th annual contest, showcasing unique and powerful works across the industry.Genentech axes $3B Adaptimmune cell therapy deal.

Fierce Pharma Sits Down with Ora | Fierce Pharma

In a statement to Fierce Pharma, Regeneron said it believes that the allegations are “without merit. In October of 2022, the company had laid out a contingency plan to “refocus its resources” on . Each year from 2017, when Teva recorded sales of $22.Even after the heady highs of the COVID-19 era, the contract development and manufacturing organization (CDMO) realm remains one of biopharma’s buzziest fields. In a lawsuit filed after a whistleblower tipoff, the DOJ alleges Regeneron knowingly submitted false . presence, Novartis will adopt a “U.The new operating model will “reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes,” Bayer said in a statement. Teva taps Royalty to bankroll long-acting schizophrenia drug .Pfizer CEO Bourla says company ready to execute in a ‚pivotal‘ 2023: report.2 billion on its plant in Holly Springs, North Carolina, for a total investment so far of more than $3. Noah Tong Apr 5, 2024 10:02am.Teva’s sales increase in the fourth quarter is evidence that the company is heading in the right direction under new CEO Richard Francis.WuXi Bio foresees this year and the first half of 2024 as the “most challenging” time periods for its business. UCB Biotechnology Industry Organization Pfizer.-first mindset,” increasing the share of U.

20 Pharma Blogs to Watch - SimplerQMS

Pfizer’s new launches will include five vaccines, two oncology medicines and two immuno-inflammation drugs, CEO Albert .Biopharma is a fast-growing world where big ideas come along daily. Merck emerged victorious with an offer of $10.91 billion) during this year’s first quarter after bringing in a 2022 haul of 10.In this episode of The Top Line, we talk with Fierce’s Max Bayer and Angus Liu about the most important news coming from this year’s annual BIO conference.

Layoff Tracker 2023

Currently, around 940 people are employed at Pfizer’s Sandwich facility in the U. He joined the Fierce team after working 26 years as a newspaper sportswriter.By Fraiser Kansteiner Nov 14, 2023 10:40am. This year, the company twice had to slash its revenue forecast for 2023, largely because it didn’t foresee COVID-19 product demand falling so ., called an update to a top priority at Pfizer, the company on Thursday .

MedTech

The top 10 Big Pharmas for diversity, equity and inclusion in 2022. Fierce Life Sciences Events.Collectively known as the HuFriedyGroup, the 1,500-employee dental division manufactures dental instruments, PPE and sedation systems. Now, the company’s Groton, Connecticut, site is .In OASIS 1, Novo said that if all participants had adhered to treatment, the results would have been more dramatic, with an average weight loss of 17. will be diagnosed at an advanced stage. accord became final in late December, the same month the company said the MITC would eventually be able to .The top 10 drugs losing US exclusivity in 2024. The new structure is expected to be fully operational by the end of 2022, the spokesperson . That was down from 9,610 on the same date in 2021.By Kevin Dunleavy Jan 16, 2024 3:40pm.

After Pfizer’s exit, UCB splits from industry trade group BIO

Nov 13, 2023 11:40am. The disclosure comes as a result of . (z_wei/iStock/Getty Images Plus) Earlier this month, Pfizer’s $3.BMS touts latest Opdivo data as I-O battle heads to new front. All FiercePharma stories. By Angus Liu Jun 12, 2023 2:19pm. Amgen layoffs Horizon Therapeutics.

RSS Feeds

Special Reports

Biotech

Haleon layoffs U. DOJ sues Regeneron for under-reporting Eylea price to Medicare. By Kevin Dunleavy Oct 24, 2023 2:41pm.

Fierce Pharma Biopharma News & Insights

And about 20% to 29% of all endometrial .

Top 5 Pharma Trends That Dominate The Pharma Industry in 2020

In a warning letter published last week, the FDA chided Centaur for production shortfalls found during an inspection of the company’s Maharashtra, India, drug ingredients plant. Fierce Healthcare. The unrelenting churning of time means many things to many people.The Centrum maker pulled down 2. Animal Health .With layoffs hitting employees on both sides of the Atlantic, Pfizer’s $3.

Bayer needs acquisition to meet oncology sales goal, exec says

The new figures for Pfizer continue a trend.Johnson & Johnson formally announced its standalone healthcare company in 2021, later branding the new business as Kenvue. UCB is heading into 2024 with several new approvals under its belt, but it’s leaving its membership in the . He compiles Fierce Pharma’s COVID Tracker and writes about .Kevin Dunleavy is a staff writer for Fierce Pharma. The company expects a “positive turnaround” by the second half of next year.After 55 new drug approvals at the FDA last year, biopharma and the U.

Amid restructuring, Novartis plots layoffs in development group

Fierce Pharma Homepage Pharma .Gilead Sciences‘ Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce.